News about Clinical Trials

First patient outside U.S. treated in global Kevzara clinical trial program for patients with severe COVID-19

 First patient outside U.S. treated in global Kevzara clinical trial program for patients with severe COVID-19

The first patient outside of the U.S. has been treated as part of a global clinical program evaluating Kevzara in patients hospitalized with severe COVID-19. The global clinical program has now been initiated in Italy, Spain, Germany, France, Canada, Russia and the United States ? all countries that have been impacted by COVID-19

Clinical Trials | 30/03/2020 | By Darshana

Pfizer’s sNDA for Eucrisa to treat children as young as 3 months of age with mild-to-moderate AD receives US FDA approval

 Pfizer’s sNDA for Eucrisa to treat children as young as 3 months of age with mild-to-moderate AD receives US FDA approval

Pfizer announced that the US Food and Drug Administration (FDA) has approved its supplemental New Drug Application (sNDA) for Eucrisa (crisaborole) ointment, 2%, extending the lower age limit from 24 months down to 3 months in children with mild-to-moderate atopic dermatitis (AD), also known as eczema

Clinical Trials | 26/03/2020 | By Darshana

Luminex Provides Update on SARS-CoV-2 Validation Testing Efforts

 Luminex Provides Update on SARS-CoV-2 Validation Testing Efforts

Luminex Corporation announced today that four independent clinical laboratories have validated laboratory developed tests (LDTs) for automated, rapid detection of the SARS-CoV-2 virus using the sample-to-answer ARIES® System

Clinical Trials | 18/03/2020 | By Darshana

Denovo Biopharma Announces Breakthrough Discovery of a Novel Genetic Biomarker for DB104 for Depression

 Denovo Biopharma Announces Breakthrough Discovery of a Novel Genetic Biomarker for DB104  for Depression

Denovo Biopharma LLC, a pioneer in applying precision medicine to develop innovative therapies, today announced it has successfully discovered a novel genetic biomarker associated with DB104 response to treat depression using its proprietary biomarker discovery platform

Clinical Trials | 15/03/2020 | By Darshana

Biocon & Mylan Win Patent Litigation Asserted by Sanofi for Insulin Glargine Device

 Biocon & Mylan Win Patent Litigation Asserted by Sanofi for Insulin Glargine Device

Biocon Ltd.announced today that it has won a U.S. court ruling that invalidated a Sanofi patent on the Insulin Glargine device , removing a key legal hurdle to commercializing Semglee® (Insulin Glargine) co-developed with Mylan, in the U.S.

Clinical Trials | 15/03/2020 | By Darshana


We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology
Subscribe to our newsletter